Study on administration of 1,5-anhydro-D-fructose in C57BL/6J mice challenged with high-fat diet

BMC Endocrine Disorders

Volumn 10, Issue , 2010, Pages

  Mei, Jie ^a   Yu, Shukun ^a,b   Ahrén, Bo ^a  

^a LUND UNIVERSITY   (Sweden)

^b DANISCO A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

1,5 ANHYDROFRUCTOSE; DRINKING WATER; FRUCTOSE; GLUCOSE; INSULIN; MONOSACCHARIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; C57BL 6 MOUSE; CONTROLLED STUDY; FEMALE; FLUID INTAKE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; IMPAIRED GLUCOSE TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; INSULIN RELEASE; LIPID DIET; MOUSE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET;

EID: 77957902686     PISSN: None     EISSN: 14726823     Source Type: Journal    
DOI: 10.1186/1472-6823-10-17     Document Type: Article

References (23)

1. Yu S. The anhydrofructose pathway. IUBMB Life 2008, 60:798-809. 10.1002/iub.125, 18785261.
2. Broberg A, Kenne L, Pedersén M. Analysis of 1,5-anhydro-D-fructose, microthecin, and 4-deoxy-glycero-hexo-2,3-diulose in algae using gas chromatography-mass spectrometry in selected ion monitoring mode. Anal Biochem 1999, 268:35-42. 10.1006/abio.1998.3013, 10036159.
3. Deffieux G, Baute R, Baute MA, Atfani M, Carpy A. 1,5-Anhydro-D-fructose, the precursor of the pyrone microthecin in Morchella vulgaris. Phytochemistry 1987, 26:1391-1393.
4. Yu S, Bojsen K, Svensson B, Marcussen J. α-1,4-Glucan lyases producing 1,5-anhydrofructose from starch and glycogen have sequence similarity to α-glucosidases. Biochim Biophys Acta 1999, 1433:1-15.
5. Giffhorn F. Fungal pyranose oxidases: occurrence, properties and biotechnical applications in carbohydrate chemistry. Appl Microbiol. Biotechnol 2000, 54:727-740. 10.1007/s002530000446, 11152063.
6. Sakuma M, Kametani S, Akanuma H. Purification and some properties of a hepatic NADPH-dependent reductase that specifically acts on 1,5-anhydro-D-fructose. J Biochem 1998, 123:189-193.
7. Yamanouchi T, Inoue T, Ichiyanagi K, Sakai T, Ogata N. 1,5-Anhydroglucitol stimulates insulin release in insulinoma cell lines. Biochim Biophys Acta 2003, 1623:82-87.
8. Baute MA, Deffieux G, Vercauteren J, Baute R, Badoc A. Enzymic activity degrading 1,4-α-glucans to ascopyrones P and T in Pezizales ad Tuberales. Phytochemistry 1993, 33:41-45.
9. Lundt I, Yu S. 1,5-Anhydro-D-fructose: biocatalytic and chemical synthetic methods for the preparation, transformation and derivatization. Carbohydr Res 2010, 345:181-190. 10.1016/j.carres.2009.11.004, 20004890.
10. Hisaku S, Takeda Y, Abe J, Muroya T, Yoshinaga K, Fujisue M. Agent for suppressing or inhibiting bacterial proliferation containing 1,5-anhydro-D-fructose. Jap Patent Appl 1999, 11-266336.
11. Fujisue M, Yoshinaga K, Muroya T, Abe J, Hizukuri S. Preparation and antioxidant activity of 1,5-anhydrofructose. J Appl Glycosci 1999, 46:439-444.
12. Yamaji K, Sarker KP, Maruyama I, Hizukuri S. Antioxidant effects of 1,5-anhydro-D-fructose, a new natural sugar, in vitro. Planta Med 2002, 68:16-19. 10.1055/s-2002-20050, 11842320.
13. Ahrén B, Holst JJ, Yu S. 1,5-Anhydro-D-fructose increases glucose tolerance by increasing GLP-1 and insulin in mice. Eur J Pharmacol 2000, 397:219-225. 10.1016/S0014-2999(00)00261-2, 10844116.
14. Ahrén B. Plasma leptin and insulin in C57BL/6J mice on a high-fat diet: relation to subsequent changes in body weight. Acta Physiol Scand 1999, 165:233-240. 10.1046/j.1365-201x.1999.00518.x, 10090336.
15. Survit RS, Kuhn CM, Cochrane C, McCubbin JA, Feinglos MN. Diet-induced type II diabetes in C57BL/6J mice. Diabetes 1988, 37:1163-1167. 10.2337/diabetes.37.9.1163, 3044882.
16. Survit RS, Feinglos MN, Rodin J, Sutherland A, Petro AE, Opara EC, Kuhn CM, Rebuffe-Scrive M. Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. Metabolism 1995, 44:645-651. 10.1016/0026-0495(95)90123-X, 7752914.
17. Moore PC, Ugas MA, Hagman DK, Parazzoli SD, Poitout V. Evidence against the involvement of oxidative stress in fatty acid inhibition of insulin secretion. Diabetes 2004, 53:2610-2616. 10.2337/diabetes.53.10.2610, 15448091.
18. Ahrén B, Scheurink AJW. Marked hyperleptinemia after high-fat diet associated with severe glucose intolerance in mice. Eur J Endocrinol 1998, 139:461-467. 10.1530/eje.0.1390461, 9820626.
19. Abeyama K, Maruyama Y, Yoshimoto Y, Yoshinaga K. Anti-inflammatory agent. Jap Patent Appl 2006, JP2006306814.
20. Abeyama K, Yoshimoto Y. Antitumor agent. Eur Patent Appl 2006, EP1686122.
21. Fiskesund R, Abeyama K, Yoshinaga K, Abe JI, Yuan Y, Yu S. 1,5-Anhydro-D-fructose and its derivatives: biosynthesis, preparation and potential medical applications. Planta Med 2010,
22. Yu S, Mei J, Ahrén B. Basic toxicology and metabolism studies of 1,5-anhydro-D-fructose using bacteria, cultured mammalian cells and rodent models. Food Chem Toxicol 2004, 42:1677-1686. 10.1016/j.fct.2004.06.004, 15354319.
23. Mei J, Yu S, Ahrén B. A 90-day toxicological evaluation of 1,5-anhydro-D-fructose in Sprague-Dawley rats. Drug Chem Toxicol 2005, 28:263-272. 10.1081/DCT-200064458, 16051552.